How should the extravasation of chemotherapy agents be managed?

The management of chemotherapy extravasation is critical because these agents can cause significant tissue damage if they leak into the surrounding tissue. The correct response emphasizes the immediate cessation of the infusion followed by the administration of an appropriate antidote, if available. This rapid response is essential to minimize tissue injury and manage potential complications.

When chemotherapy extravasates, the first step is to stop the infusion to prevent further leakage of the drug into the tissue. This action halts the progression of cell damage and allows for necessary interventions to take place. The administration of an appropriate antidote is crucial, as certain agents have specific antidotes that can mitigate or reverse tissue effects. For instance, some vesicants have designated treatments that can help to reduce the risk of more severe consequences, making this step vital in the management protocol.

The other options do not adequately address the urgency and proper protocol associated with extravasation. Continuing the infusion while monitoring can worsen the situation as it allows more of the harmful drug to seep into the tissue. Applying pressure to the infusion site is not a recommended action, as it may exacerbate the injury instead of helping it. Switching to a different vein does not solve the issue of extravasation occurring in the current site and can lead to a